北京周末执行国家集采等三批药品集采中选结果，这些患者受益

Core Insights - The Beijing Medical Insurance Bureau announced the results of the 11th batch of national drug procurement, the 26-province alliance drug procurement, and the 2025 municipal drug procurement, which will be implemented in all public medical institutions starting February 28, benefiting patients with hypertension, diabetes, and tumors [1][2]. Group 1: Drug Procurement Details - The 11th national procurement batch includes 55 types of drugs, covering common medications for infection, allergy, tumor treatment, blood sugar, blood pressure, blood lipid reduction, and anti-inflammatory pain relief [1]. - The 26-province alliance procurement focuses on frequently used clinical drugs through a cross-province alliance model to lower prices and ensure stable drug supply [1]. - The municipal drug procurement addresses regional medical needs, complementing the national and provincial alliance procurements to enhance clinical drug options [1]. Group 2: Implementation and Compliance - Medical institutions are required to sell selected drugs at zero markup based on procurement prices [1]. - From February 24, the municipal medical insurance drug procurement subsystem will adjust the prices of selected drugs, with a transition period from February 24 to 27 for institutions to complete necessary adjustments [1]. - A supervision and assessment mechanism will be established to monitor the procurement and usage of selected drugs, linking results to the overall quality evaluation of the medical insurance budget [2]. Group 3: Drug Procurement Concept - Drug procurement, or centralized volume-based procurement, consolidates the fragmented purchasing demands of medical institutions to negotiate directly with manufacturers, aiming to reduce drug prices and alleviate patients' medical expenses [3]. - The procured drugs mainly consist of off-patent medications with sufficient market competition, most of which are already included in the national medical insurance drug list, allowing patients to benefit from both price reductions and insurance reimbursements [3].